Viewing Study NCT00412893

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-02-03 @ 2:56 AM
Study NCT ID: NCT00412893
Status: COMPLETED
Last Update Posted: 2024-12-10
First Post: 2006-12-18
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Aspergillosis View
None Invasive Fungal Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Invasive fungal disease View
None BAL8557 View
None Isavuconazole View
None ASP9766 View
None Filamentous fungi View
None Phase III View
None Aspergillus species View